分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis

Renfeng Xu, Saifan Zeng, Ting Zhang, Jingjing Wu, Juan Tang, Hongqin Yang, Feng Gao

Journal:Biomaterials Advances

IF:6.7

DOI:10.1016/j.bioadv.2026.214927

PMID:42090779

Published:2026-05-03

research field:肿瘤学生物力学药理学癌症生物学分子医学

Abstract

Mechanical properties are directly related to the efficacy of tumor chemotherapy. • Atomic force microscopy can well quantify the mechanical properties of tumors. • Regulating ECM stiffness through YAP1/BCl2/Bax to modulate the efficacy of cisplatin in lung cancer. Lung adenocarcinoma (LUAD) remains one of the leading causes of cancer-related deaths worldwide, and cisplatin (DDP) resistance severely limits the efficacy of first-line chemotherapy. Extracellular matrix (ECM) stiffening is a hallmark of solid tumors, yet how it modulates chemosensitivity remains unclear. This study demonstrates that matrix stiffness activates the mechanosensor YAP1 in lung adenocarcinoma, which in turn establishes an apoptosis-refractory state by upregulating Bcl2 and downregulating Bax. Functional experiments establish the YAP1–Bax axis as the core pathway, while clinical correlation analysis reveals that YAP1 expression significantly predicts poor post-chemotherapy survival. Our findings reveal a mechanism by which mechanical cues desensitize mitochondrial apoptosis through YAP1-driven transcriptional reprogramming, providing both new insights into chemoresistance mechanisms and a potential biomarker for treatment response.

本文使用的Yeasen产品

购物车
客服
转染试用